| Jeffrey Carlton Roeser, MD | |
|
446 N Reading Rd Ste 301, Ephrata, PA 17522-9802 | |
| (717) 733-6546 | |
| (717) 733-6011 |
| Full Name | Jeffrey Carlton Roeser |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 6 Years |
| Location | 446 N Reading Rd Ste 301, Ephrata, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023506763 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD480940 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tower Health At Home - Berks | Wyomissing, PA | Home health agency |
| Grane Hospice Care, Inc | King of prussia, PA | Hospice |
| Wellspan Ephrata Community Hospital | Ephrata, PA | Hospital |
| Reading Hospital | West reading, PA | Hospital |
| Highlands At Wyomissing | Wyomissing, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Luminis Health Medical Group, Llc | 2860447315 | 431 |
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
Scientists have long known that the blood pressure drops after exercise but the mechanism has not been fully elucidated. A new study shows that bacteria in the mouth, which produce nitrite, is key to the whole process. The use of mouthwash to reduce the number of these bacteria prevents the expected benefit of exercise on the blood pressure.
Symplmed announced today that the U.S. Food and Drug Administration has accepted for review its New Drug Application (NDA) for investigational drug Prestalia, the first single-pill, fixed-dose combination (FDC) of perindopril arginine and amlodipine besylate for the treatment of hypertension in the U.S. Symplmed filed the application under section 505(b)(2) consistent with FDA's guidance.
The most comprehensive international study to date on the association between mobile phone use and brain cancers has not shown a strong causal link between the two but research on their relationship needs to continue, Professor Bruce Armstrong from the School of Public Health says.
The Vascular Disease Foundation announced the launch of its new "Peripheral Arterial Disease Exercise Training Toolkit: A Guide for Health Care Professionals." This toolkit was developed jointly by the Vascular Disease Foundation and the American Association of Cardiovascular and Pulmonary Rehabilitation and may be accessed online at www.vdf.org/rehab-toolkit/index.php
A novel immunotherapy clinical trial underway now at The University of Kansas Cancer Center has enrolled the first patients in the world to receive what many doctors and researchers believe is the future of cancer treatment.
› Verified 6 days ago
| Entity Name | Johns Hopkins Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578598868 PECOS PAC ID: 8325943707 Enrollment ID: O20031220000065 |
News Archive
Scientists have long known that the blood pressure drops after exercise but the mechanism has not been fully elucidated. A new study shows that bacteria in the mouth, which produce nitrite, is key to the whole process. The use of mouthwash to reduce the number of these bacteria prevents the expected benefit of exercise on the blood pressure.
Symplmed announced today that the U.S. Food and Drug Administration has accepted for review its New Drug Application (NDA) for investigational drug Prestalia, the first single-pill, fixed-dose combination (FDC) of perindopril arginine and amlodipine besylate for the treatment of hypertension in the U.S. Symplmed filed the application under section 505(b)(2) consistent with FDA's guidance.
The most comprehensive international study to date on the association between mobile phone use and brain cancers has not shown a strong causal link between the two but research on their relationship needs to continue, Professor Bruce Armstrong from the School of Public Health says.
The Vascular Disease Foundation announced the launch of its new "Peripheral Arterial Disease Exercise Training Toolkit: A Guide for Health Care Professionals." This toolkit was developed jointly by the Vascular Disease Foundation and the American Association of Cardiovascular and Pulmonary Rehabilitation and may be accessed online at www.vdf.org/rehab-toolkit/index.php
A novel immunotherapy clinical trial underway now at The University of Kansas Cancer Center has enrolled the first patients in the world to receive what many doctors and researchers believe is the future of cancer treatment.
› Verified 6 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
Scientists have long known that the blood pressure drops after exercise but the mechanism has not been fully elucidated. A new study shows that bacteria in the mouth, which produce nitrite, is key to the whole process. The use of mouthwash to reduce the number of these bacteria prevents the expected benefit of exercise on the blood pressure.
Symplmed announced today that the U.S. Food and Drug Administration has accepted for review its New Drug Application (NDA) for investigational drug Prestalia, the first single-pill, fixed-dose combination (FDC) of perindopril arginine and amlodipine besylate for the treatment of hypertension in the U.S. Symplmed filed the application under section 505(b)(2) consistent with FDA's guidance.
The most comprehensive international study to date on the association between mobile phone use and brain cancers has not shown a strong causal link between the two but research on their relationship needs to continue, Professor Bruce Armstrong from the School of Public Health says.
The Vascular Disease Foundation announced the launch of its new "Peripheral Arterial Disease Exercise Training Toolkit: A Guide for Health Care Professionals." This toolkit was developed jointly by the Vascular Disease Foundation and the American Association of Cardiovascular and Pulmonary Rehabilitation and may be accessed online at www.vdf.org/rehab-toolkit/index.php
A novel immunotherapy clinical trial underway now at The University of Kansas Cancer Center has enrolled the first patients in the world to receive what many doctors and researchers believe is the future of cancer treatment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Carlton Roeser, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 733-6546 | Jeffrey Carlton Roeser, MD 446 N Reading Rd Ste 301, Ephrata, PA 17522-9802 Ph: (717) 733-6546 |
News Archive
Scientists have long known that the blood pressure drops after exercise but the mechanism has not been fully elucidated. A new study shows that bacteria in the mouth, which produce nitrite, is key to the whole process. The use of mouthwash to reduce the number of these bacteria prevents the expected benefit of exercise on the blood pressure.
Symplmed announced today that the U.S. Food and Drug Administration has accepted for review its New Drug Application (NDA) for investigational drug Prestalia, the first single-pill, fixed-dose combination (FDC) of perindopril arginine and amlodipine besylate for the treatment of hypertension in the U.S. Symplmed filed the application under section 505(b)(2) consistent with FDA's guidance.
The most comprehensive international study to date on the association between mobile phone use and brain cancers has not shown a strong causal link between the two but research on their relationship needs to continue, Professor Bruce Armstrong from the School of Public Health says.
The Vascular Disease Foundation announced the launch of its new "Peripheral Arterial Disease Exercise Training Toolkit: A Guide for Health Care Professionals." This toolkit was developed jointly by the Vascular Disease Foundation and the American Association of Cardiovascular and Pulmonary Rehabilitation and may be accessed online at www.vdf.org/rehab-toolkit/index.php
A novel immunotherapy clinical trial underway now at The University of Kansas Cancer Center has enrolled the first patients in the world to receive what many doctors and researchers believe is the future of cancer treatment.
› Verified 6 days ago
Sarah Maurice, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 | |
Dr. Eugene Lee Camerino, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 | |
Palak Pranav Mehta, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 | |
Cheryl Lynne Gardner, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 460 North Reading Rd, Ephrata, PA 17522 Phone: 717-738-4070 Fax: 717-738-3558 | |
Dr. So Hyang Park, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 N Reading Rd, Ephrata, PA 17522 Phone: 717-738-4070 Fax: 717-738-3558 | |
Karla M Ludwig, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 N Reading Rd, Ephrata, PA 17522 Phone: 717-721-4840 Fax: 717-738-3558 |